New technologies and analysis methods are enabling genomic structural variants (SVs) to be detected with ever-increasing accuracy, resolution, and comprehensiveness. Translating these methods to routine research and clinical practice requires robust benchmark sets. We developed the first benchmark set for identification of both false negative and false positive germline SVs, which complements recent efforts emphasizing increasingly comprehensive characterization of SVs. To create this benchmark for a broadly consented son in a Personal Genome Project trio with broadly available cells and DNA, the Genome in a Bottle (GIAB) Consortium integrated 19 sequence-resolved variant calling methods, both alignment-and de novo assembly-based, from short-, linked-, and long-read sequencing, as well as optical and electronic mapping. The final benchmark set contains 12745 isolated, sequence-resolved insertion and deletion calls ≥50 base pairs (bp) discovered by at least 2 technologies or 5 callsets, genotyped as heterozygous or homozygous variants by long reads. The Tier 1 benchmark regions, for which any extra calls are putative false positives, cover 2.66 Gbp and 9641 SVs supported by at least one diploid assembly. Support for SVs was assessed using svviz with short-, linked-, and long-read sequence data. In general, there was strong support from multiple technologies for the benchmark SVs, with 90 % of the Tier 1 SVs having support in reads from more than one technology. The Mendelian genotype error rate was 0.3 %, and genotype concordance with manual curation was >98.7 %. We demonstrate the utility of the benchmark set by showing it reliably identifies both false negatives and false positives in high-quality SV callsets from short-, linked-, and long-read sequencing and optical mapping.
Introduction
Many diseases have been linked to structural variations (SVs), most often defined as genomic changes at least 50 base pairs (bp) in size, but SVs are challenging to detect accurately. Conditions linked to SVs include autism, 1 schizophrenia, cardiovascular disease, 2 Huntington's Disease, and several other disorders. 3 Far fewer SVs exist in germline genomes relative to small variants, but SVs affect more base pairs and each SV may be more likely to impact phenotype. [4] [5] [6] While next generation sequencing technologies can detect many SVs, each technology and analysis method has different strengths and weaknesses. To enable the community to benchmark these methods, the Genome in a Bottle Consortium (GIAB) here developed benchmark SV calls and benchmark regions for the son (HG002/NA24385) in a broadly consented and available Ashkenazi Jewish trio from the Personal Genome Project, 7 which are disseminated as National Institute of Standards and Technology (NIST) Reference Material 8392. 8, 9 Many approaches have been developed to detect SVs from different sequencing technologies.
Microarrays can detect large deletions and duplications, but not with sequence-level resolution. 10 Since short reads (<<1000bp) are often smaller than or similar to the SV size, bioinformaticians have developed a variety of methods to infer SVs, including using split reads, discordant read pairs, depth of coverage, and local de novo assembly. Linked reads add long-range (100kb+) information to short reads, enabling phasing of reads for haplotype-specific deletion detection, large SV detection, [11] [12] [13] and diploid de novo assembly. 14 Long reads (>>1000bp), which can fully traverse many more SVs, further enable SV detection, often sequence-resolved, using mapped reads, 15, 16 local assembly after phasing long reads, 6, 17 and global de novo assembly. 18, 19 Finally, optical mapping and electronic mapping provide an orthogonal approach capable of determining the approximate size and location of insertions, deletions, inversions, and translocations while spanning even very large SVs. [20] [21] [22] GIAB recently published benchmark sets for small variants for seven genomes, 9, 23 and the Global Alliance for Genomics and Health Benchmarking Team established best practices for using these and other benchmark sets to benchmark germline variants. 24 These benchmark sets are widely used in developing, optimizing, and demonstrating new technologies and bioinformatics methods, as well as part of clinical laboratory validation. 12, 15, 25, 26 Benchmarking tool development has also been critical to standardize definitions of performance metrics, robustly compare VCFs with different representations of complex variants, and enable stratification of performance by variant type and genome context. Benchmark set and benchmarking tool development is even more challenging and important for SVs given the wide spectrum of types and sizes of SVs, complexity of SVs (particularly in repetitive genome contexts), and that many SV callers output imprecise or imperfect breakpoints and sequence changes.
Several previous efforts have developed well-characterized SVs in human genomes. The 1000 Genomes Project catalogued copy-number variants (CNVs) and SVs in thousands of individuals. 27, 28 A subset of CNVs from NA12878 were confirmed and further refined to those with support from multiple technologies using SVClassify . 29 The unique collection of Sanger sequencing from the HuRef sample has also been used to characterize SVs. 30, 31 Long reads were used to broadly characterize SVs in a haploid hydatidiform mole cell line. 32 The Parliament framework was developed to integrate short and long reads for the HS1011 sample. 33 Most recently, the Human Genome Structural Variation Consortium and the Genome Reference Consortium used short, linked, and long reads to develop phased, sequence-resolved SV callsets, greatly expanding the number of SVs in three trios from 1000 Genomes, particularly in tandem repeats. 6, 34 Detection of somatic SVs in cancer genomes is a very active field, with numerous methods in development. [35] [36] [37] While some of the problems are similar between germline and somatic SV detection, somatic detection is complicated by the need to distinguish somatic from germline events in the face of differential coverage, subclonal mutations and impure tumor samples, amongst others. 38, 39 We build on these efforts by focusing on enabling anyone to assess both false negatives (FNs) AND false positives (FPs) for a well-defined set of sequence-resolved insertions and deletions ≥50 bp in specified genomic regions. We evaluate the utility of the benchmark for measuring precision and recall of diverse callsets from different technologies. While we include SVs only discovered by long reads, we exclude regions with more than one SV, as these regions are not handled by current SV comparison and benchmarking tools. We also cluster calls by their specific sequence, improving upon previous work that clustered loosely by position, overlap, or size; we address challenges in comparing calls with different representations in repetitive regions to enable the integration of a wide variety of sequence-resolved input callsets from different technologies.
Results

Candidate SV callsets differ by sequencing technology and analysis method
We generated 28 sequence-resolved candidate SV callsets from 19 variant calling methods from 4 sequencing technologies for the Ashkenazi son (HG002), as well as 20 callsets each from the parents HG003 and HG004. We integrated a total of 68 callsets, where we define a "callset" as the result of a particular variant calling method using data from one or more technologies for an individual. The variant calling methods included 3 small variant callers, 9 alignment-based SV callers, and 7 global de novo assembly-based SV callers. The technologies included short-read (Illumina and Complete Genomics), linked-read (10x Genomics), and long-read (PacBio) sequencing technologies as well as SV size estimates from optical (Bionano) and electronic (Nabsys) mapping. Figure 1 shows the number of SVs overlapping between our sequence-resolved callsets from different variant calling methods and technologies for HG002. In general, the concordance for insertions is lower than the concordance for deletions, except among long-read callsets, mostly because current short read-based methods do not sequence-resolve large insertions. This highlights the importance of developing benchmark SV sets to identify which callset is correct when they disagree, and potentially when both are incorrect even when they agree. 40 shows the number of SVs overlapping between the individual SV caller and technologies split between insertions (upper left) and deletions (lower right). The diagonal highlights the overall number of SVs per SV caller. Overall we obtained a quite diverse picture of SVs calls supported by each SV caller and technology, highlighting the need for benchmark sets.
Figure 1: Pairwise comparison of sequence-resolved SV callsets obtained from multiple technologies and SV callers for SVs ≥50bp from HG002 . Heatmap produced by SURVIVOR
Design objectives for our benchmark SV set
Our objective was that, when comparing any callset (the "test set" or "query set") to the "benchmark set," it reliably identifies FPs and FNs. In practice, we aimed to demonstrate that most (ideally approaching 100%) of conflicts (both FPs and FNs) between any given test set and the benchmark set were actually errors in the test set. This goal is typically challenging to meet across the wide spectrum of sequencing technologies and calling methods. Secondarily, to the extent possible, our goal was for the benchmark set to include a large, representative variety of SVs in the human genome. By integrating results from a large suite of high-throughput, whole genome methods, each with their own signatures of bias, biases from any particular method are minimized. We systematically establish the "benchmark regions" in this genome in which we are close to comprehensively characterizing SVs. We exclude regions from our benchmark if we could not reliably reach near-comprehensive characterization (e.g., in segmental duplications). Importantly, we demonstrate the benchmark set is fit for purpose for benchmarking by presenting examples of comparisons of SVs from multiple technologies and manual curation of discordant calls.
Benchmark set is formed by clustering and evaluating support for candidate SVs
We integrated all sequence-resolved candidate SV callsets to form the benchmark set, using the process described in Figure 2 . Since candidate SV calls often differ in their exact breakpoints, size, and/or sequence change estimated, we used a new method called SVanalyzer ( https://svanalyzer.readthedocs.io ) to cluster calls estimating similar sequence changes. This new method was needed to account for both differences in SV representation (e.g., different alignments within a tandem repeat) and differences in the precise sequence change estimated. Of the 498876 candidate insertion and deletion calls ≥50 bp in the son-father-mother trio, 296761 were unique after removing duplicate calls and calls that were the same when taking into account representation differences (e.g., different alignment locations in a tandem repeat). When clustering variants for which the estimated sequence change was <20 % divergent, 128715 unique SVs remain. We then filtered to retain SV clusters supported by: more than one technology, ≥5 callsets from a single technology, Bionano, or Nabsys. The 30062 SVs remaining were then evaluated and genotyped in each member of the trio using svviz 41 to align reads to reference and alternate alleles from PCR-free Illumina, Illumina 6 kbp mate-pair, haplotype-partitioned 10x Genomics, and PacBio with and without haplotype partitioning. We further filtered for SVs covered in HG002 by 8 or more PacBio reads (mean coverage of about 60), with at least 25% of PacBio reads supporting the alternate allele and consistent genotypes from all technologies that could be confidently assessed with svviz. This left 19748 SVs. The number of PacBio reads supporting the SV allele and reference allele for each benchmark SV is in Supplementary Figure 1 .
In our evaluations of these well-supported SVs, we found that 12745 were isolated, while 7003 (35 %) were within 1000 bp of another well-supported SV call. Upon manual curation, we found that the variants within 1000 bp of another variant were mostly in tandem repeats and fell into several classes: (1) true complex variants with more than one SV call on the same haplotype, (2) true compound heterozygous variant with different SV calls on each haplotype, and (3) regions where some methods had the correct SV call and others had inaccurate sequence, size, or breakpoint estimates, but svviz still aligned reads to it because reads matched it better than the reference. We chose to exclude these clustered SVs from our benchmark set because methods do not exist to confidently distinguish between the above classes, nor do SV comparison tools for robust benchmarking of complex and compound structural variants.
Finally, to enable assessment of both FNs and FPs, benchmark regions were defined using diploid assemblies and candidate variants. These regions were designed such that our benchmark variant callset should contain almost all true SVs within these regions. These regions define our Tier 1 benchmark set, which spans 2.66 Gbp and includes 9641 benchmark SVs. These regions exclude 1837 of the 12745 SVs because they were within 50 bp of a 20 bp to 49 bp indel; they exclude an additional 856 SVs within 50 bp of a candidate SV for which no consensus genotype could be determined; and they exclude an additional 411 calls that were not fully supported by a diploid assembly as the only SV in the region. A large number of annotations are associated with the Tier 1 SV calls (e.g., number of discovery callsets from each technology, number of reads supporting reference and alternate alleles from each technology, number of callsets with exactly matching sequence estimates), which enable users to filter to a more specific callset. We also define Tier 2 regions that delineate 6007 additional regions in addition to the 12745 isolated SVs, which are regions with substantial evidence for one or more SVs but we could not precisely determine the SV. For the Tier 2 regions, multiple SVs within 1 kb or in the same or adjacent tandem repeats are counted as a single region, so many SV callers would be expected to call more than 6007 SVs in these regions.
Figure 2: Process to integrate SV callsets from different technologies and analysis methods and form the benchmark set.
Approximately 0.5 million input SV calls were locally clustered based on their estimated sequence change, and we kept only those discovered by at least two technologies or at least 5 callsets in the trio. We then used svviz with short, linked, and long reads to evaluate and genotype these calls, keeping only those with a consensus heterozygous or homozygous variant genotype in the son. We filtered potentially complex calls in regions with multiple discordant SV calls, as well as regions around 20 bp to 49 bp indels, and our final Tier 1 benchmark set included 12745 total insertions and deletions ≥50 with 9641 inside the 2.66 Gbp of the genome where diploid assemblies had no additional SVs beyond those in our benchmark set. We also define a Tier 2 set of 6007 additional regions where there was substantial support for one or more SVs but the precise SV was not yet determined.
Benchmark calls are well-supported
The 12745 isolated SV calls had size distributions consistent with previous work detecting SVs from long reads, 6, 15, 17, 26 with the clear, expected peaks for Alu insertions and deletions near 300 bp and for full-length LINE1 insertions and deletions near 6000 bp ( Figure 3 ). SVs have an exponentially decreasing abundance vs. size if they fall in tandem repeats longer than 100 bp in the reference.
Interestingly, there are more large insertions than large deletions in tandem repeats, despite insertions being more challenging to detect. This is consistent with previous work detecting SVs from long read sequencing 15, 17 and may result from instability of tandem repeats in the BAC clones used to create the reference genome. 42 (a) (b) when in fact they were likely homozygous variant or complex (2:232734665 and 8:43034905).
Supplementary Table 1 is a detailed contingency table of genotypes in the son, father, and mother.
The GIAB community also manually curated a random subset of SVs from different size ranges in the union of all discovered SVs. 43 When comparing the consensus genotype from expert manual curation to our benchmark SV genotypes, 627/635 genotypes agreed. Most discordant genotypes were identified as complex by the curators, with a 20 bp to 49 bp indel near an SV in our benchmark set, because they were asked to include indels 20 bp to 49 bp in size in their curation, whereas our SV benchmark set focused on SVs >49 bp.
Benchmark set is useful for identifying false positives and false negatives across technologies
Our goal in designing this SV benchmark set was that, when comparing any callset to our benchmark VCF within the benchmark BED file, most putative FPs and FNs should be errors in the tested callset. To determine if we meet this goal, we benchmarked several callsets from assembly-and non-assembly-based methods that use short or long reads. We developed a new benchmarking tool truvari ( https://github.com/spiralgenetics/truvari ) to perform these comparisons at a matching stringency requiring the variant size to be within 30 % of the benchmark size, and the position to be within 2kb.
Truvari enables users to specify matching stringency for size, sequence, and/or distance. An alternative benchmarking tool developed more recently, which has more sophisticated sequence matching, is SVanalyzer SVbenchmark ( https://github.com/nhansen/SVanalyzer/blob/master/docs/svbenchmark.rst ).
Upon manual curation of a random 10 FP and FN insertions and deletions (40 total SVs) from each callset being compared to the benchmark, nearly all of the FPs and FNs were errors in each of the tested callsets and not errors in the GIAB callset ( Figure 5 ). The version of the truvari tool we used could not always account for all differences in representation, so if manual curation determined both the benchmark and test sets were correct, they were counted as correct. The only notable exception to the high GIAB callset accuracy was for FP insertions from the PacBio caller pbsv (https://github.com/PacificBiosciences/pbsv), for which about half of the putative FP insertions were true insertions missed in the benchmark regions.
This suggests the GIAB callset may be missing approximately 5 % of true insertions in the benchmark regions. When comparing BioNano calls to our benchmark, we also found one region with multiple insertions where our benchmark had a heterozygous 1412 bp insertion at chr6:65000859, but we incorrectly called a homozygous 101 bp insertion in a nearby tandem repeat at chr6:65005337, when in fact there is an insertion of approximately 5400 bp in this tandem repeat on the same haplotype as the 1412 bp insertion, and the 101 bp insertion is on the other haplotype.
Figure 5: Summary of manual curation of putative FPs and FNs when benchmarking short and long reads against the v0.6 benchmark set.
Most FP and FN SVs were determined to be correct in the v0.6 benchmark (green), but some were partially correct due to missing part of the SV in the region (blue), were incorrect in v0.6 (orange), or were in difficult locations where the evidence was unclear (black).
Technologies and variant callers have different strengths and weaknesses
Amongst the extensive candidate SV callsets we collected from different technologies and analyses, we found that certain SV types and sizes in our benchmark set were discovered by fewer methods ( Figure 6 ).
In particular, more methods discovered sequence-resolved deletions than insertions, more methods discovered SVs not in tandem repeats, and the most methods discovered deletions smaller than 1000 bp not in tandem repeats. These results confirm the intuition that SV detection outside of repeats is simpler than within repeats, and that deletions are simpler to detect than insertions since deletions do not require mapping to new sequence. Figure 7 further shows that the fewest SVs were missed by the union of all long read discovery methods. The only exception was (50 to 99) bp deletions, which were all found by at least one short read discovery method. Many insertions >300 bp that were not discovered by any short read method could be accurately genotyped in this sample by short reads. Interestingly, many deletions and insertions <300 bp that were not genotyped accurately by short reads were discovered by at least one short read-based method. This likely reflects a limitation of the heuristics we used for genotyping, which reduces the false positive rate but may increase the false negative rate. Both discovery and genotyping based on short reads had limitations for SVs in tandem repeats. These results confirm the importance of long read data for comprehensive SV detection. into SVs overlapping (TRgt100bp) and not overlapping (noTRgt100bp) tandem repeats longer than 100 bp in the reference. SVs are also stratified by size into 50 bp to 99 bp (050to99), 100 bp to 299 bp (100to299), 300 bp to 999 bp (300to999), and ≥1000 bp (gt1000).
Sequence-resolved benchmark calls have annotations related to base-level accuracy
We provide sequence-resolved calls in our benchmark set to enable benchmarking of sequence change predictions, but importantly not all calls are perfect on a base-level. When discovered SVs from multiple callsets have exactly matching sequence changes, we output the sequence change from the largest number of callsets. However, as shown in Figure 8 , not all benchmark SVs have calls that exactly matched between discovery callsets. For deletions not in tandem repeats, at least 99 % of the calls had exact matches, but there were no exact matches for ~5% of DELs in TRs, and for large insertions no exact matches existed for ~50% of the calls. This is likely because SVs in tandem repeats and larger insertions are more likely to be discovered only by methods using relatively noisy long reads. , and into SVs overlapping (TRgt100bp) and not overlapping (noTRgt100bp) tandem repeats longer than 100 bp in the reference. SVs are also stratified by size into 50 bp to 99 bp (050to99), 100 bp to 299 bp (100to299), 300 bp to 999 bp (300to999), and ≥1000 bp (gt1000).
Discussion
We 26 and Oxford Nanopore ultra long reads 44 ), new and updated SV callers, and new diploid de novo assemblies. We are also refining the integration methods (e.g., to include inversions), and developing an integration pipeline that is easier to reproduce. In the next several months, we plan to release improved benchmark sets for GRCh37 and GRCh38 using these new methods similar to how we have maintained and updated the small variant callsets for these samples over time.
We will also use the reproducible integration pipeline developed here to benchmark SVs for all 7 GIAB genomes. We will continue to refine these methods to access more difficult SVs in more difficult regions of the genome. Finally, we plan to develop a manuscript describing best practices for using this benchmark set to benchmark any other SV callset, similar to our recent publication for small variants, 24 with refined SV comparison tools and standardized definitions of performance metrics.
Data availability
Raw sequence data were previously published in Scientific Data 
Methods
Code availability
Scripts for integrating candidate structural variants to form the benchmark set in this manuscript are available in a GitHub repository at https://github.com/jzook/genome-data-integration/tree/master/StructuralVariants/NISTv0.6. Publicly available software used to generate input callsets is described below in the methods.
Tier 1 Benchmark Integration process
The GIAB v0.6 Tier 1 Benchmark SV Set was generated using the following heuristics from the union vcf generated from the discovery callsets described below (68 callsets from 19 3. If two or more supported variants ≥50 bp were within 1000 bp of each other, they were excluded because they are potentially complex or inaccurate.
In addition, benchmark regions were formed with the following process: 
6.
High confidence regions are regions in #4 covered by at least 1 assembly minus the regions in #5.
7.
Further exclude any regions in the Tier 2 bed file of unresolved and clusters of variants, unless the Tier 2 region overlaps a Tier 1 PASS call. 
Tier 2 Benchmark Integration Process
We designed the draft Tier 2 benchmark set as a less conservative set of regions in which there appeared to be good evidence for at least one SV, but there were multiple SVs within 1 kb, multiple SVs within a tandem repeat, and/or different SV callers had different results for reasons that were not yet resolved. The process for forming the Tier 2 regions was:
1. Add 1000 bp to each side of any variants with the FILTER "ClusteredCalls" or 3. After removing variants discovered by at least 2 technologies or 5 callsets (the inverse of those tested in the Tier 1 process above), cluster variants within 1000 bp (without considering type or sequence change), and find regions with clusters having calls from at least 2 technologies or 5
callsets. Expand these regions to completely encompass any overlapping tandem repeats (after merging tandem repeats within 50bp and adding 5 bp on each side).
4.
Remove any regions from #1 and #2 that have any overlap with a Tier 1 benchmark call, and take the union of the resulting regions and the regions from #3. Merge regions within 50bp, and the result is the Tier 2 bed.
Clustering of sequence-resolved variants with SVmerge
Structural variants are frequently flanked by stretches of repeated sequence which obscure the true position of the structural event. For this reason, we used a repeat-aware method to compare sequence-resolved structural variants, rather than relying on size and overlap-based rules. The program SVmerge, part of the SVanalyzer package (http://github.com/nhansen/SVanalyzer) was used to compare pairs of non-identical structural variant calls and cluster them based on distance measures. To calculate these measures of distance, SVmerge constructs alternate haplotype sequences corresponding to a common, widened region of the reference which includes all bases altered by either of the two variants.
The two resulting alternate haplotypes are then compared by global alignment (Needleman Wunsch, as implemented in the the edlib software library), 45 and the resulting alignment is used to calculate three normalized measures of difference: (1) the edit distance between the two alternate haplotypes, (2) the size difference in base pairs between the two alternate haplotypes, and (3) the maximum shift of coordinates in the global alignment between the two haplotypes. Each of these distances is then normalized by dividing by the mean length of the longer allele (reference or alternate) for each of the two variants.
To combine the structural variant calls into clusters, SVmerge creates an undirected graph in which variant calls are nodes and edges exist between pairs of calls having all three distances less than or equal to specified maximum values. Variants are then merged into a single cluster if they are within the same connected component of the resulting graph.
Trio+linked read phased vcf and haplotype-partitioned bam files
To produce a chromosome-length phasing of small variants for the Ashkenazim trio, we combined variant calls from Real Time Genomics The single sample 10x Genomics VCF files were combined into multi-sample VCF using bcftools and all VCFs were split by chromosome (to facilitate easy parallelization with Snakemake). Then, WhatsHap (version 0.15+14.ga105b78) 46 was used in pedigree-aware mode 47 using the following command line:
whatshap phase --ped AJ.ped --indels --reference hg19.fasta rtg.vcf 10x-merged.vcf | bgzip > output.vcf
This vcf with whatshap haplotag was used to partition reads in the PacBio bam files for svviz and manual curation.
Progression of GIAB SV Benchmark Versions
Several draft SV benchmark sets were developed and evaluated by the GIAB community, and feedback from end users and new technologies and SV callers were used to improve each subsequent version. A description of each version is below: 
Phased-SV
Haplotype-specific assemblies and associated callsets for HG002 were generated using Phased-SV (github.com/mchaisso/phasedsv) with parameters {"recall_bin": 100, "cov_cutoff": 3, "tr_cluster_size": 6, "depth" : 50}. Reads were aligned to GRCh38 using blasr (github.com/mchaisso/blasr) retaining quality value information. SNP phasing from ftp:// ftp-trace.ncbi.nlm.nih.gov/giab/ftp/data/AshkenazimTrio/analysis/10XGenomics_ChromiumGenome _LongRanger2.0_06202016/HG002_NA24385_son/NA24385_GRCh37.vcf.gz was used to partition reads by haplotype, and local assemblies were performed using canu. 59 
08252015/
PacBio data used for each member of the trio is in NCBI SRA SRX1033793-SRX1033798
PacBio Falcon (haploid)
A non-diploid assembly was generated using the Falcon assembly method 18 and genotyped. Output calls were filtered according to the "PASS" filter and a minimal count of alternate-supporting reads of 5. SVs in centromeres and telomeres were excluded, with the list provided with Delly developers. Calls were compared to the goldset using truvari, and manually verified in IGV.
Illumina mapping-based MetaSV
The same MetaSV callset described above was benchmarked against v0.6.
Illumina assembly-based SpiralBGA
The same Spiral BioGraph methods described above was benchmarked against v0.6
PacBio mapping-based pbsv PacBio 10 kb CCS reads (ftp://ftp-trace.ncbi.nlm.nih.gov/giab/ftp/data/AshkenazimTrio/HG002_NA24385_son/PacBio_CCS_10k b/) were aligned to hs37d5 with minimap2 version 2.11-r797 ( https://github.com/lh3/minimap2 ). 61 Structural variants were called with pbsv version 2.0.0 ( https://github.com/PacificBiosciences/pbsv ) with default parameters. Variants were evaluated against the GIAB v0.6 benchmark set using Truvari commit bb51e7575 with "--passonly --pctsim 0 -r 2000 --giabreport". Ten randomly selected variants were evaluated in IGV for each combination of variant type (insertion, deletion); Truvari error type (false positive, false negative); and overlap with tandem repeats (yes, no). The pbsv VCF files are at: 
Other SV Callsets
We generated additional SV callsets, which were not used in forming or evaluating the v0.6 SV benchmark set, but some were used in previous benchmark versions or are a resource for community evaluations.
Illumina mapping-based TARDIS These call sets are generated jointly for the trio used TARDIS 62 
Illumina mapping-based MrCaNaVaR
We used mrCaNaVaR tool 63 with default parameters to characterize large (>10 Kb) segmental duplications and deletions, and calculate genic copy numbers. The mrCaNaVaR tool is a reimplementation of an earlier read depth based algorithm designed to detect segmental duplications.
Briefly, we remapped the Illumina reads to the repeat-masked reference genome assembly, and identified regions of read depth higher than the genome average (specifically 3 standard deviations above average) after GC% error correction. The output VCF and BED files are under: ftp:// ftp-trace.ncbi.nlm.nih.gov/giab/ftp/data/AshkenazimTrio/analysis/BilkentUni_IlluminaHiSeq_TARD IS_mrCaNaVar_05212019/ ftp:// ftp-trace.ncbi.nlm.nih.gov/giab/ftp/data/ChineseTrio/analysis/BilkentUni_IlluminaHiSeq_TARDIS_ mrCaNaVar_05212019/
PacBio mapping-based PALMER
We used PALMER (https://github.com/mills-lab/PALMER) to identify non-reference human-specific Long Interspersed Element-1 (L1Hs) insertions and characterize significant hallmarks of these retrotransposon insertions. PALMER firstly pre-masks aligned long-read sequences containing endogenous reference L1Hs and then searches against L1.3 (GenBank Accession: L19088) sequences to detect non-reference L1Hs insertions within the remaining unmasked sequences. After we obtained the preliminary non-reference L1Hs insertions from PALMER, error-correction and local-alignment processes were manipulated by using CANU 59 ( https://github.com/marbl/canu ) and blasr
